Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Other Accumulated Expenses: 2013-2015

Historic Other Accumulated Expenses for Tvardi Therapeutics (TVRD) over the last 2 years, with Dec 2015 value amounting to $186,000.

  • Tvardi Therapeutics' Other Accumulated Expenses rose 66.07% to $186,000 in Q4 2015 from the same period last year, while for Dec 2015 it was $186,000, marking a year-over-year increase of 66.07%. This contributed to the annual value of $186,000 for FY2015, which is 66.07% up from last year.
  • Tvardi Therapeutics' Other Accumulated Expenses amounted to $186,000 in Q4 2015, which was up 116.28% from $86,000 recorded in Q3 2015.
  • Tvardi Therapeutics' 5-year Other Accumulated Expenses high stood at $186,000 for Q4 2015, and its period low was $22,000 during Q1 2014.
  • Over the past 3 years, Tvardi Therapeutics' median Other Accumulated Expenses value was $57,000 (recorded in 2015), while the average stood at $81,222.
  • Over the last 5 years, Tvardi Therapeutics' Other Accumulated Expenses had its largest YoY gain of 159.09% in 2015, and its largest YoY loss of 69.85% in 2015.
  • Tvardi Therapeutics' Other Accumulated Expenses (Quarterly) stood at $55,000 in 2013, then spiked by 103.64% to $112,000 in 2014, then soared by 66.07% to $186,000 in 2015.
  • Its last three reported values are $186,000 in Q4 2015, $86,000 for Q3 2015, and $41,000 during Q2 2015.